Who owns CENTURY THERAPEUTICS INC?
- Ticker: IPSC
- CUSIP Number: 15673t100
Tip: Access positions for across all investors
Analyze quarterly positions in Century Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Century Therapeutics stock
Who bought or sold CENTURY THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Casdin Capital | 3.2M | $11M | 0% | Dec 2023 |
|
Avidity Partners Management | 1.4M | $4.5M | 23% | Dec 2023 |
|
DAFNA Capital Management | 1.3M | $4.3M | 0% | Dec 2023 |
|
Vanguard Group | 1.1M | $3.7M | 0% | Dec 2023 |
|
Tang Capital Management | 1.1M | $3.5M | 100% | Dec 2023 |
|
Baker Bros. Advisors | 798k | $2.6M | -31% | Dec 2023 |
|
Federated Investors | 619k | $2.1M | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 149k | $494k | 1% | Dec 2023 |
|
Millennium Management | 139k | $461k | 100% | Dec 2023 |
|
Citadel Advisors | 104k | $344k | 66% | Dec 2023 |
|
Jacobs Levy Equity Management | 101k | $335k | -41% | Dec 2023 |
|
New York Life Investment Management | 100k | $332k | -3% | Dec 2023 |
|
Wealth Enhancement Advisory Services | 78k | $327k | 0% | Mar 2024 |
|
Bank of New York Mellon | 71k | $296k | -22% | Mar 2024 |
|
Squarepoint Ops | 56k | $185k | -35% | Dec 2023 |
|
CornerCap Investment Counsel | 52k | $171k | 0% | Dec 2023 |
|
Goldman Sachs Group | 45k | $148k | -8% | Dec 2023 |
|
Bank of America Corporation | 43k | $142k | 6% | Dec 2023 |
|
Rhumbline Advisers | 33k | $109k | -4% | Dec 2023 |
|
Dimensional Fund Advisors | 33k | $108k | 16% | Dec 2023 |
|
Barclays | 32k | $107k | 676% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 29k | $95k | 2469% | Dec 2023 |
|
Parametrica Management | 28k | $92k | 0% | Dec 2023 |
|
UBS Group | 26k | $85k | 53% | Dec 2023 |
|
Jane Street | 18k | $59k | 100% | Dec 2023 |
|
Hrt Financial | 18k | $58k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 15k | $50k | -43% | Dec 2023 |
|
Virtu Financial | 14k | $47k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 14k | $46k | 0% | Dec 2023 |
|
SG Americas Securities | 13k | $43k | 24% | Dec 2023 |
|
American International | 12k | $39k | 0% | Dec 2023 |
|
Alliancebernstein | 12k | $38k | -9% | Dec 2023 |
|
Abel Hall | 10k | $33k | 100% | Dec 2023 |
|
Neuberger Berman Group | 10k | $33k | 100% | Dec 2023 |
|
Founders Financial Securities | 10k | $42k | 0% | Mar 2024 |
|
Royal Bank of Canada | 7.4k | $24k | 73% | Dec 2023 |
|
Wells Fargo & Company | 7.2k | $24k | 25% | Dec 2023 |
|
Citigroup | 3.5k | $12k | 367% | Dec 2023 |
|
Russell Investments | 2.9k | $9.5k | 492% | Dec 2023 |
|
Simplex Trading | 2.4k | $10k | 723% | Mar 2024 |
|
Legal & General Group | 2.1k | $7.0k | 0% | Dec 2023 |
|
Summit Investment Advisors | 905.00 | $3.0k | 0% | Dec 2023 |
|
Amalgamated Bank | 706.00 | $3.0k | -63% | Mar 2024 |
|
GAMMA Investing | 295.00 | $1.2k | 68% | Mar 2024 |
|
NISA Investment Advisors | 111.00 | $368.997300 | 100% | Dec 2023 |
|
Covestor | 3.00 | $0 | 100% | Dec 2023 |
|
CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Century Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Gladius Capital Management | Sep 2023 | 9.8k | $20k |
Ohio Pers | Sep 2023 | 8.7k | $17k |
China Universal Asset Management | Sep 2023 | 1.5k | $3.0k |
Daiwa Securities Group | Sep 2023 | 159.00 | $0 |